377 related articles for article (PubMed ID: 34372568)
1. The Mechanism behind Influenza Virus Cytokine Storm.
Gu Y; Zuo X; Zhang S; Ouyang Z; Jiang S; Wang F; Wang G
Viruses; 2021 Jul; 13(7):. PubMed ID: 34372568
[TBL] [Abstract][Full Text] [Related]
2. Role of the Innate Cytokine Storm Induced by the Influenza A Virus.
Gu Y; Hsu AC; Pang Z; Pan H; Zuo X; Wang G; Zheng J; Wang F
Viral Immunol; 2019; 32(6):244-251. PubMed ID: 31188076
[TBL] [Abstract][Full Text] [Related]
3. New fronts emerge in the influenza cytokine storm.
Guo XJ; Thomas PG
Semin Immunopathol; 2017 Jul; 39(5):541-550. PubMed ID: 28555383
[TBL] [Abstract][Full Text] [Related]
4. The role of influenza A virus-induced hypercytokinemia.
Wei F; Gao C; Wang Y
Crit Rev Microbiol; 2022 Mar; 48(2):240-256. PubMed ID: 34353210
[TBL] [Abstract][Full Text] [Related]
5. A(H7N9) virus results in early induction of proinflammatory cytokine responses in both human lung epithelial and endothelial cells and shows increased human adaptation compared with avian H5N1 virus.
Zeng H; Belser JA; Goldsmith CS; Gustin KM; Veguilla V; Katz JM; Tumpey TM
J Virol; 2015 Apr; 89(8):4655-67. PubMed ID: 25673714
[TBL] [Abstract][Full Text] [Related]
6. Cytokine storm plays a direct role in the morbidity and mortality from influenza virus infection and is chemically treatable with a single sphingosine-1-phosphate agonist molecule.
Oldstone MB; Rosen H
Curr Top Microbiol Immunol; 2014; 378():129-47. PubMed ID: 24728596
[TBL] [Abstract][Full Text] [Related]
7. The cytokine storm of severe influenza and development of immunomodulatory therapy.
Liu Q; Zhou YH; Yang ZQ
Cell Mol Immunol; 2016 Jan; 13(1):3-10. PubMed ID: 26189369
[TBL] [Abstract][Full Text] [Related]
8. Innate Immunity and the Inter-exposure Interval Determine the Dynamics of Secondary Influenza Virus Infection and Explain Observed Viral Hierarchies.
Cao P; Yan AW; Heffernan JM; Petrie S; Moss RG; Carolan LA; Guarnaccia TA; Kelso A; Barr IG; McVernon J; Laurie KL; McCaw JM
PLoS Comput Biol; 2015 Aug; 11(8):e1004334. PubMed ID: 26284917
[TBL] [Abstract][Full Text] [Related]
9. Innate immune evasion strategies of influenza viruses.
Hale BG; Albrecht RA; García-Sastre A
Future Microbiol; 2010 Jan; 5(1):23-41. PubMed ID: 20020828
[TBL] [Abstract][Full Text] [Related]
10. Influenza A Virus Infection, Innate Immunity, and Childhood.
Coates BM; Staricha KL; Wiese KM; Ridge KM
JAMA Pediatr; 2015 Oct; 169(10):956-63. PubMed ID: 26237589
[TBL] [Abstract][Full Text] [Related]
11. Respiratory epithelial cells in innate immunity to influenza virus infection.
Sanders CJ; Doherty PC; Thomas PG
Cell Tissue Res; 2011 Jan; 343(1):13-21. PubMed ID: 20848130
[TBL] [Abstract][Full Text] [Related]
12. [Cytokine storm in avian influenza].
Us D
Mikrobiyol Bul; 2008 Apr; 42(2):365-80. PubMed ID: 18697437
[TBL] [Abstract][Full Text] [Related]
13. A consideration of publication-derived immune-related associations in Coronavirus and related lung damaging diseases.
Geifman N; Whetton AD
J Transl Med; 2020 Aug; 18(1):297. PubMed ID: 32746922
[TBL] [Abstract][Full Text] [Related]
14. Influenza Virus Neuraminidase Engages CD83 and Promotes Pulmonary Injury.
Ma N; Li X; Jiang H; Dai Y; Xu G; Zhang Z
J Virol; 2021 Jan; 95(3):. PubMed ID: 33177200
[TBL] [Abstract][Full Text] [Related]
15. Distinct inflammatory profiles distinguish COVID-19 from influenza with limited contributions from cytokine storm.
Mudd PA; Crawford JC; Turner JS; Souquette A; Reynolds D; Bender D; Bosanquet JP; Anand NJ; Striker DA; Martin RS; Boon ACM; House SL; Remy KE; Hotchkiss RS; Presti RM; O'Halloran JA; Powderly WG; Thomas PG; Ellebedy AH
Sci Adv; 2020 Dec; 6(50):. PubMed ID: 33187979
[TBL] [Abstract][Full Text] [Related]
16. The Establishment and Validation of the Human U937 Cell Line as a Cellular Model to Screen Immunomodulatory Agents Regulating Cytokine Release Induced by Influenza Virus Infection.
Liu G; Chen S; Hu A; Zhang L; Sun W; Chen J; Tang W; Zhang H; Liu C; Ke C; Chen X
Virol Sin; 2019 Dec; 34(6):648-661. PubMed ID: 31286365
[TBL] [Abstract][Full Text] [Related]
17. What is the oligoadenylate synthetases-like protein and does it have therapeutic potential for influenza?
Alcorn JF; Sarkar SN
Expert Rev Respir Med; 2015 Feb; 9(1):1-3. PubMed ID: 25544107
[TBL] [Abstract][Full Text] [Related]
18. Severe human lower respiratory tract illness caused by respiratory syncytial virus and influenza virus is characterized by the absence of pulmonary cytotoxic lymphocyte responses.
Welliver TP; Garofalo RP; Hosakote Y; Hintz KH; Avendano L; Sanchez K; Velozo L; Jafri H; Chavez-Bueno S; Ogra PL; McKinney L; Reed JL; Welliver RC
J Infect Dis; 2007 Apr; 195(8):1126-36. PubMed ID: 17357048
[TBL] [Abstract][Full Text] [Related]
19. Influenza virus N-linked glycosylation and innate immunity.
York IA; Stevens J; Alymova IV
Biosci Rep; 2019 Jan; 39(1):. PubMed ID: 30552137
[TBL] [Abstract][Full Text] [Related]
20. Quantification of Cytokine Storms During Virus Infections.
Yuan S; Jiang SC; Zhang ZW; Fu YF; Hu J; Li ZL
Front Immunol; 2021; 12():659419. PubMed ID: 34079547
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
